Cancer
Conditions
Keywords
Patient reported outcomes, Smart t-shirt, Wearable, Patient-generated health data, Biometric sensor technology, Cancer
Brief summary
The study will assess the feasibility of using the ChronolifeTM smart t-shirt for home monitoring of vital parameters in cancer patients during their treatment course. This study will bring new insights to how wearables and biometric data can be used as a part of symptom recognition in cancer patients during treatment course in the quest of increasing patients' quality of life.
Detailed description
Collecting biometric sensor data by wearables is an example of real-time patient-generated health data that can provide vital and detailed objective information about patients. This may have the potential to improve quality of oncological treatment and increase patients' quality of life. Studies have shown that there may be a dissimilar perception on symptoms and side effects between patients and health care professionals. Wearables may help identifying symptoms earlier. A new design of a wearable is a smart t-shirt. A smart t-shirt has sensors embedded in the fabric which generate measurement flows. This new tool provide more precise information without recall and reporting bias which may have the potential to lead to a better and more accurate cancer treatment.
Interventions
DEVICEWearable sensor
The patients will be asked to wear a smart shirt. The shirt is designed with multiple sensors and electrodes fully embedded which engender 6 different measurement flows continuously. The smart t-shirt system is washable, and patients can wash and dry this t-shirt anytime, thus the shirt can be worn repeatedly.
Sponsors
Rigshospitalet, Denmark
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Danish cancer patients ≥18 years in antineoplastic treatment at Department of Oncology Rigshospitalet Denmark * Both patients in curative and palliative care will be eligible * 10 cancer patients under 39 years * 10 cancer patients over 65 years * Able to read and speak Danish
Exclusion criteria
* Serious cognitive deficits
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants who could wear the smart t-shirt preferably 8 hours pr. day during the three weeks study period | 2 weeks | To assess the feasibility of using the ChronolifeTM smart t-shirt based on the completion rate which is defined as the number of included patients using the smart t-shirt at least 12 hours pr. day during the three weeks study period. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Technical feasibility | 2 weeks | To assess technical feasibility in a Danish healthcare system including data acquisition rate and data completeness. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Changes in heart rate | 2 weeks | Changes in heart rate (beat per minute) will be presented descriptively. |
| Changes in thoracic impedance | 2 weeks | Changes in thoracic impedance (kOhm) will be presented descriptively. |
| Changes in physical activity | 2 weeks | Changes in physical activity (steps) will be presented descriptively. |
| Changes in skin temperature | 2 weeks | Changes in skin temperature (°C) will be presented descriptively. |
| Changes in respirations frequency | 2 weeks | Changes in respirations frequency (respiration per minute) will be presented descriptively. |
Countries
Denmark
Outcome results
None listed